Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
Kirsten E. Wiens, Pinyi Nyimol Mawien, John Rumunu, Damien Slater, Forrest K. Jones, Serina Moheed, Andrea Caflish, Bior K. Bior, Iboyi Amanya Jacob, Richard Lino Loro Lako, Argata Guracha Guyo, Olushayo Oluseun Olu, Sylvester Maleghemi, Andrew Baguma, Juma John Hassen, Sheila K. Baya, Lul Deng, Justin Lessler, Maya N. Demby, Vanessa Sanchez, Rachel Mills, Clare Fraser, Richelle C. Charles, Jason B. Harris, Andrew S. Azman, Joseph F. Wamala
doi: https://doi.org/10.1101/2021.03.08.21253009
Kirsten E. Wiens
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Pinyi Nyimol Mawien
2Republic of South Sudan Ministry of Health, Juba, South Sudan
John Rumunu
2Republic of South Sudan Ministry of Health, Juba, South Sudan
Damien Slater
3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
Forrest K. Jones
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Serina Moheed
3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
Andrea Caflish
4Displacement Tracking Matrix, International Organization for Migration, Juba, South Sudan
Bior K. Bior
2Republic of South Sudan Ministry of Health, Juba, South Sudan
Iboyi Amanya Jacob
2Republic of South Sudan Ministry of Health, Juba, South Sudan
Richard Lino Loro Lako
2Republic of South Sudan Ministry of Health, Juba, South Sudan
Argata Guracha Guyo
5World Health Organization, Juba, South Sudan
Olushayo Oluseun Olu
5World Health Organization, Juba, South Sudan
Sylvester Maleghemi
5World Health Organization, Juba, South Sudan
Andrew Baguma
5World Health Organization, Juba, South Sudan
6Kabale University School of Medicine, Department of Microbiology and Immunology
Juma John Hassen
5World Health Organization, Juba, South Sudan
Sheila K. Baya
5World Health Organization, Juba, South Sudan
Lul Deng
2Republic of South Sudan Ministry of Health, Juba, South Sudan
Justin Lessler
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Maya N. Demby
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Vanessa Sanchez
3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
Rachel Mills
3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
Clare Fraser
3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
Richelle C. Charles
3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
7Department of Medicine, Harvard Medical School, Boston, MA, USA
Jason B. Harris
3Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
8Department of Pediatrics, Harvard Medical School, Boston, MA, USA
Andrew S. Azman
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
9Médecins Sans Frontières, Geneva, Switzerland
10Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Joseph F. Wamala
5World Health Organization, Juba, South Sudan
Posted March 12, 2021.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
Kirsten E. Wiens, Pinyi Nyimol Mawien, John Rumunu, Damien Slater, Forrest K. Jones, Serina Moheed, Andrea Caflish, Bior K. Bior, Iboyi Amanya Jacob, Richard Lino Loro Lako, Argata Guracha Guyo, Olushayo Oluseun Olu, Sylvester Maleghemi, Andrew Baguma, Juma John Hassen, Sheila K. Baya, Lul Deng, Justin Lessler, Maya N. Demby, Vanessa Sanchez, Rachel Mills, Clare Fraser, Richelle C. Charles, Jason B. Harris, Andrew S. Azman, Joseph F. Wamala
medRxiv 2021.03.08.21253009; doi: https://doi.org/10.1101/2021.03.08.21253009
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
Kirsten E. Wiens, Pinyi Nyimol Mawien, John Rumunu, Damien Slater, Forrest K. Jones, Serina Moheed, Andrea Caflish, Bior K. Bior, Iboyi Amanya Jacob, Richard Lino Loro Lako, Argata Guracha Guyo, Olushayo Oluseun Olu, Sylvester Maleghemi, Andrew Baguma, Juma John Hassen, Sheila K. Baya, Lul Deng, Justin Lessler, Maya N. Demby, Vanessa Sanchez, Rachel Mills, Clare Fraser, Richelle C. Charles, Jason B. Harris, Andrew S. Azman, Joseph F. Wamala
medRxiv 2021.03.08.21253009; doi: https://doi.org/10.1101/2021.03.08.21253009
Subject Area
Subject Areas
- Addiction Medicine (393)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2882)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12622)
- Forensic Medicine (10)
- Gastroenterology (813)
- Genetic and Genomic Medicine (4483)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (911)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4251)
- Nursing (228)
- Nutrition (622)
- Oncology (2226)
- Ophthalmology (634)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1182)
- Primary Care Research (488)
- Public and Global Health (6829)
- Radiology and Imaging (1503)
- Respiratory Medicine (909)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)